Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Establishing the impact of effective donor-specific antibody (DSA) desensitisation in haploidentical and mismatched donor haematopoietic stem cell transplants: An Australian experience

Louis Do, Elizabeth O'Flaherty, Claire Dowsing, Peter Shuttleworth, Peter Bardy, Shafqat Inam, Ameya Hanamshet, Duncan Purtill, Abir Bhattacharyya, Gillian Huang, David Ritchie, John Moore, Ashish Bajel

Blood (2025) 146 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2025-4199

Published: 2025

Journal Articles

Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).

Nicola Hurst, Charles G. Mullighan, Sue L. Heatley, Kathryn Robinson, Silke Danner, Uwe Hahn, Jeff Szer, Peter Shuttleworth, Rosie Hoyt, Anthony P. Schwarer, Jenny Muirhead, Kenneth Bradstock, Lisa Miller, Peter G. Bardy

Blood (2007) 110 (11): 2909.

https://doi.org/10.1182/blood.V110.11.2909.2909

Published: 2007

Journal Articles

Tissue Iron Overload Is Common Post Transplantation (Allo BMT) and Is Associated with Red Cell Transfusion Load and HFE Genotype.

Duncan Carradice, MBBS, Peter Shuttleworth, RN, Jeffrey Szer, MBBS FRACP, Andrew Roberts, MBBS PhD FRACP FRCP, Andrew Grigg, MBBS FRACP FRCPA

Blood (2004) 104 (11): 2262.

https://doi.org/10.1182/blood.V104.11.2262.2262

Published: 2004

Journal Articles

Pamidronate Therapy for One Year after Allogeneic Bone Marrow Transplantation (AlloBMT) Reduces Bone Loss from the Lumbar Spine, Femoral Neck and Total Hip.

Andrew C. Grigg, MD, Peter Shuttleworth, RN, John Reynolds, PhD, Jeff Szer, MD, Anthony P. Schwarer, MD, Andrew W. Roberts, MD, Ken F. Bradstock, MD, Chi-Hung Hui, MD, Richard Herrmann, MD, Peter Ebeling, MD

Blood (2004) 104 (11): 2253.

https://doi.org/10.1182/blood.V104.11.2253.2253

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Establishing the impact of effective donor-specific antibody (DSA) desensitisation in haploidentical and mismatched donor haematopoietic stem cell transplants: An Australian experience

Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).

Tissue Iron Overload Is Common Post Transplantation (Allo BMT) and Is Associated with Red Cell Transfusion Load and HFE Genotype.

Pamidronate Therapy for One Year after Allogeneic Bone Marrow Transplantation (AlloBMT) Reduces Bone Loss from the Lumbar Spine, Femoral Neck and Total Hip.

Email alerts

ASH Publications

American Society of Hematology

Update search

Establishing the impact of effective donor-specific antibody (DSA) desensitisation in haploidentical and mismatched donor haematopoietic stem cell transplants: An Australian experience

Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).

Tissue Iron Overload Is Common Post Transplantation (Allo BMT) and Is Associated with Red Cell Transfusion Load and HFE Genotype.

Pamidronate Therapy for One Year after Allogeneic Bone Marrow Transplantation (AlloBMT) Reduces Bone Loss from the Lumbar Spine, Femoral Neck and Total Hip.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only